Background Ocular toxoplasmosis is common across all regions of the world. Understanding of the epidemiology and approach to diagnosis and treatment have evolved recently. In November 2020, an international group of uveitis-specialised ophthalmologists formed the International Ocular Toxoplasmosis Study Group to define current practice. Methods 192 Study Group members from 48 countries completed a 36-item survey on clinical features, use of investigations, indications for treatment, systemic and intravitreal treatment with antiparasitic drugs and corticosteroids, and approach to follow-up and preventive therapy. Results For 77.1% of members, unilateral retinochoroiditis adjacent to a pigmented scar accounted for over 60% of presentations, but diverse atypical presentations were also reported. Common complications included persistent vitreous opacities, epiretinal membrane, cataract, and ocular hypertension or glaucoma. Most members used clinical examination with (56.8%) or without (35.9%) serology to diagnose typical disease but relied on intraocular fluid testing-usually PCR-in atypical cases (68.8%). 66.1% of members treated all non-pregnant patients, while 33.9% treated selected patients. Oral trimethoprim-sulfamethoxazole was first-line therapy for 66.7% of members, and 60.9% had experience using intravitreal clindamycin. Corticosteroid drugs were administered systemically by 97.4%; 24.7% also injected corticosteroid intravitreally, almost always in combination with an antimicrobial drug (72.3%). The majority of members followed up all (60.4%) or selected (35.9%) patients after resolution of acute disease, and prophylaxis against recurrence with trimethoprim-sulfamethoxazole was prescribed to selected patients by 69.8%. Conclusion Our report presents a current management approach for ocular toxoplasmosis, as practised by a large international group of uveitis-specialised ophthalmologists.
Current practice in the management of ocular toxoplasmosis / Kengadhevi, Yogeswaran; João M, Furtado; Bahram, Bodaghi; Janet M, Matthews; Accorinti, Massimo; Agarwal, Aniruddha; Agarwal, Mamta; Joon Ahn, Seong; Akyol, Nurettin; Alvarez, Carlos; Amer, Radgonde; Androudi, Sofia; Arcinue, Cheryl; Arellanes-Garcia, Lourdes; Fernando Arevalo, J; Arrieta-Bechara, Cesar; Artaraz, Joseba; Ata, Ashraf; Kalinina Ayuso, Viera; Babu, Kalpana; Bansal, Reema; Becker, Matthias; Karen Bigornia-Arriola, Lyll; Biswas, Jyotirmay; Blanco-Esteban, Ana; Bodaghi, Bahram; Bursztyn, Marcelo; Jose Capella, Maria; Carreño, Ester; Chan, Wei-Chun; Chang, Yo-Chen; Chao, Yu-Jang; Cheja-Kalb, Rashel; Cimino, Luca; Clemmensen, Kåre; Cocho, Lidia; Elena Concha-Del-Rio, Luz; Conrad, Diana; Das, Dipankar; Davis, Janet; De Boer, Joke; Denisova, Ekaterina; Derzko-Dzulynsky, Larissa; De Simone, Luca; Deuter, Christoph; Díaz-Cascajosa, Jesús; Dorokhova, Oleksandra; Duarte, Gonzalo; Ebrahimiadib, Nazanin; Elyashiv, Sivan; Emami-Naeini, Parisa; Helene Errera, Marie; Fonollosa, Alex; Fortin, Eric; Fraser-Bell, Samantha; Funk, Marion; Garza-Leon, Manuel; Garweg, Justus; Géhl, Zsuzsanna; Gepstein, Raz; Gerges, Terese; Gimenez, Alex; Goto, Hiroshi; Gottlieb, Chloe; Gugleta, Konstantin; Gupta, Vishali; Gurbaxani, Avinash; Habot-Wilner, Zohar; Hall, Anthony; Hashida, Noriyasu; Henry, Christopher; Hosseini, Maryam; Hsi-Fu, Chen; Hunchangsith, Boonsiri; Hwang, De-Kuang; Shiou Hwang, Yih; Invernizzi, Alessandro; Saeb Iriqat, Salam; Ishak, Hamisah; Islam, Bulbul; Iwahashi, Chiharu; Jódar-Márquez, Margarita; Julien, Bouleau; Kaburaki, Toshikatsu; Kadayifçilar, Sibel; Kamoi, Koju; Kansupada, Kashyap; Kao, Tzu-En; Kaplan, Alexander; Keino, Hiroshi; H Kempen, John; Khairallah, Moncef; Kim, Min; Kim, Seong-Woo; Kozyreff, Alexandra; Kuijpers, Robert; Kusuhara, Sentaro; Y Lai, Timothy Y; Laithwaite, Jenny; Lang, Blerta; Igo Larrocea, Maria; Laure, Caspers; Seungkyu Lee, Christopher; Hwan Lee, Ji; Lim, Lyndell; Llorenç, Victor; Lobo-Chan, Ann-Marie; Lourthai, Preeyachan; Mahendradas, Padmamalini; Makhoul, Dorine; Redondo Marcos, Irene; Espinosa Martinez, Cynthia; Martínez-Costa, Lucía; Mccluskey, Peter; Mili-Boussen, Ilhem; Miserocchi, Elisabetta; Mochizuki, Manabu; Oli Mohamed, Shelina; I Murray, Philip; Nakai, Kei; Nakano, Satoko; Nakhoul, Nakhoul; Namba, Kenichi; Nascimento, Heloisa; Neri, Piergiorgio; Fariza Ngah, Nor; Nguyen, John; Dong Nguyen, Quan; Niederer, Rachael; Oguma, Aya; Ohno, Shigeaki; Ohta, Kouichi; A Okada, Annabelle; Okhravi, Narciss; Özdal, Pinar; Özyazgan, Yılmaz; Palestine, Alan; Paroli, Maria Pia; Aa Partida, Jorge; Pavesio, Carlos; Pedemonte-Sarrias, Eduard; Pichi, Francesco; Pierre, Lefebvre; Pleyer, Uwe; Przeździecka-Dołyk, Joanna; Radosavljevic, Aleksandra; Rahman, Zahedur; Voorduin Ramos, Stephanie; Rao, Narsing; Rauer, Ola; Judice Relvas, Lia; Richards, Josephine; Rodriguez-Garcia, Alejandro; Sainz-de-la-Maza, Maite; Sánchez, Beatriz; Sandar, Hla; Sar, Shaul; Pb Schmidt, Luiz; Yew Sen, Yuen; Ls Sevila, Juan; Sheu, Shwu-Jiuan; Shulman, Shiri; Cunha Signorelli, Monica; Silpa-Archa, Sukhum; Smith, Justine; Smith, Wendy; Sofia, Ovi; Somkijrungroj, Thanapong; Sreekantam, Sreekanth; Sudharshan, Sridharan; Takase, Hiroshi; Takeuchi, Masaru; Tappeiner, Christoph; Tay-Kearney, Mei-Ling; Teuchner, Barbara; E Thorne, Jennifer; Touhami, Sara; Toumanidou, Victoria; Trittibach, Peter; Tugal-Tutkun, Ilknur; Tumulak, Mayjane; Nur Utami, Anna; Vadboncoeur, Julie; Van Os, Luc; Vitor Vasconcelos-Santos, Daniel; Vazquez, Erika; Willermain, François; Za Win, May; Wu, Lihteh; Yalçındağ, Nilüfer; Yanai, Ryoji; Yang, Peizeng; Yawata, Nobuyo; Zborovska, Oleksandra; Zierhut, Manfred; Esteban-Ortega Smith, Mar; R, Justine. - In: BRITISH JOURNAL OF OPHTHALMOLOGY. - ISSN 0007-1161. - (2022). [10.1136/bjophthalmol-2022-321091]
Current practice in the management of ocular toxoplasmosis
Massimo Accorinti;Maria Pia Paroli;
2022
Abstract
Background Ocular toxoplasmosis is common across all regions of the world. Understanding of the epidemiology and approach to diagnosis and treatment have evolved recently. In November 2020, an international group of uveitis-specialised ophthalmologists formed the International Ocular Toxoplasmosis Study Group to define current practice. Methods 192 Study Group members from 48 countries completed a 36-item survey on clinical features, use of investigations, indications for treatment, systemic and intravitreal treatment with antiparasitic drugs and corticosteroids, and approach to follow-up and preventive therapy. Results For 77.1% of members, unilateral retinochoroiditis adjacent to a pigmented scar accounted for over 60% of presentations, but diverse atypical presentations were also reported. Common complications included persistent vitreous opacities, epiretinal membrane, cataract, and ocular hypertension or glaucoma. Most members used clinical examination with (56.8%) or without (35.9%) serology to diagnose typical disease but relied on intraocular fluid testing-usually PCR-in atypical cases (68.8%). 66.1% of members treated all non-pregnant patients, while 33.9% treated selected patients. Oral trimethoprim-sulfamethoxazole was first-line therapy for 66.7% of members, and 60.9% had experience using intravitreal clindamycin. Corticosteroid drugs were administered systemically by 97.4%; 24.7% also injected corticosteroid intravitreally, almost always in combination with an antimicrobial drug (72.3%). The majority of members followed up all (60.4%) or selected (35.9%) patients after resolution of acute disease, and prophylaxis against recurrence with trimethoprim-sulfamethoxazole was prescribed to selected patients by 69.8%. Conclusion Our report presents a current management approach for ocular toxoplasmosis, as practised by a large international group of uveitis-specialised ophthalmologists.File | Dimensione | Formato | |
---|---|---|---|
Yogeswaran_Current practice in_2022.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
272.12 kB
Formato
Adobe PDF
|
272.12 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.